Literature DB >> 18511607

Bacterial DNA and endothelial damage in haemodialysis patients.

Ana Merino1, Sonia Nogueras, Tania García-Maceira, Mariano Rodríguez, Alejandro Martin-Malo, Rafael Ramirez, Julia Carracedo, Pedro Aljama.   

Abstract

BACKGROUND: An increased percentage of CD14+CD16+ activated monocytes have been reported in peripheral blood from haemodialysis patients. The aim of this study is to investigate if a mild stimulus such as bacterial DNA (CpG-ODNs) contamination may induce an inflammatory response in CD14+CD16+ monocytes from haemodialysis patients and to value the biological consequences of this inflammatory response on endothelial cell damage.
METHODS: Circulating mononuclear cells from 20 haemodialysis patients and 15 healthy subjects were studied. CD14+CD16+ and the toll-like receptor 9 (TLR-9) expression were assessed by flow cytometry. Cell culture inserts were used to evaluate the effect of CD14+CD16+ and CpG-ODNs on endothelial cell apoptosis (measured by Tunnel). Intracellular cytokines were measured by Cytometric methods. NF-kappaB, p38 MAPK, c-Jun PI3K and MEK1/2 activity were modified by specific peptides.
RESULTS: At baseline, CD14+CD16+ have an increased expression of cytoquines and TLR-9. CpG-ODNs caused the production and release of cytoquines in CD14+CD16+, but not in CD14++ monocytes. This inflammatory response was mediated by intracellular signalling dependent on NF-kappaB, p38 MARK or c-Jun PI3K but not by MEK1/2 activation. The results of the present study also demonstrate that the inflammatory response induced by the stimulation of CD14+CD16+ by CpG DNA resulted in endothelial cell apoptosis.
CONCLUSIONS: The results of the present study demonstrate that in haemodialysis patients there is a subpopulation of pre-activated monocytes that can be stimulated by contaminant bacterial DNA. These activated cells produce and release inflammatory factors that may cause endothelial injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511607     DOI: 10.1093/ndt/gfn308

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

Review 1.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

Review 2.  Circulating Microbiota in Cardiometabolic Disease.

Authors:  Keiichi Sumida; Zhongji Han; Chi-Yang Chiu; Tahliyah S Mims; Amandeep Bajwa; Ryan T Demmer; Susmita Datta; Csaba P Kovesdy; Joseph F Pierre
Journal:  Front Cell Infect Microbiol       Date:  2022-05-03       Impact factor: 6.073

3.  Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.

Authors:  Kehui Shi; Feiqian Wang; Hongli Jiang; Hua Liu; Meng Wei; Zhigang Wang; Li Xie
Journal:  Dig Dis Sci       Date:  2014-05-15       Impact factor: 3.199

4.  Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression.

Authors:  Yang Zhao; Yan Cai; Li-Yan Cui; Wen Tang; Bo Liu; Jia-Jia Zheng; Wen-Zhe Si; Xian Wang; Ming-Jiang Xu
Journal:  Oxid Med Cell Longev       Date:  2019-03-17       Impact factor: 6.543

Review 5.  Monocytes in Uremia.

Authors:  Matthias Girndt; Bogusz Trojanowicz; Christof Ulrich
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

6.  Circulating Microbial Signatures and Cardiovascular Death in Patients With ESRD.

Authors:  Keiichi Sumida; Joseph F Pierre; Zhongji Han; Tahliyah S Mims; Praveen Kumar Potukuchi; Melana Yuzefpolskaya; Paolo C Colombo; Ryan T Demmer; Susmita Datta; Csaba P Kovesdy
Journal:  Kidney Int Rep       Date:  2021-08-04

7.  Looking beyond endotoxin: a comparative study of pyrogen retention by ultrafilters used for the preparation of sterile dialyis fluid.

Authors:  Griet Glorieux; Michael Hulko; Rose Speidel; Katrin Brodbeck; Bernd Krause; Raymond Vanholder
Journal:  Sci Rep       Date:  2014-09-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.